CHASE: An Innovative County-Level Public Health Response to the Opioid Epidemic in New York State
CHASE:针对纽约州阿片类药物流行病的创新县级公共卫生应对措施
基本信息
- 批准号:10893819
- 负责人:
- 金额:$ 83.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-15 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAcuteAddressAdoptionAgeAttentionAwarenessBlack PopulationsCOVID-19 pandemicCommunitiesContinuity of Patient CareCountyDataData AnalysesData SourcesDeath RateDecision MakingDiscriminationDisparityDrug usageEquityEthnic OriginFrequenciesGenderGeographyGoalsGrantHealthHealth Services AccessibilityHomelessnessHousingIndividualInfrastructureInfusion proceduresInterventionKentuckyLearningLegal systemManuscriptsMapsMassachusettsMeasuresModelingNaloxoneNatureNew YorkNot Hispanic or LatinoOhioOutcomeOutcome StudyOverdoseOverdose reductionParentsParticipantPatternPersonsPharmaceutical PreparationsPhasePoliciesPopulationPrevention educationPrevention strategyProcessProtocols documentationPublic HealthPublicationsPublishingRaceRacial EquityRandomizedReach, Effectiveness, Adoption, Implementation, and MaintenanceReadinessReportingResearch PersonnelResourcesRespondentRuralSiteSpecial PopulationSurveysTimeTrainingTransportationUnderserved PopulationWaiting ListsWorkarmblack mencomparative effectivenesscontextual factorsdemographicsdesigndisparity reductiondynamic systemeffectiveness evaluationethnic disparityethnic diversityethnic minorityethnic minority populationhealinghealth care availabilityhealth equityimplementation strategyinnovationmedication for opioid use disordermeetingsmemberminority communitiesnovelopioid epidemicopioid mortalityopioid overdoseopioid use disorderoverdose deathoverdose preventionpeer influencepeer networksracial disparityracial minorityracial minority populationresponsesatisfactionsexshared decision makingsocial health determinantssocial stigmasociodemographicstooltreatment as usualtrend
项目摘要
Project Summary/Abstract
This supplement aims to explore the impact of the infusion of health equity principles on overdose prevention
strategies during the implementation of the Communities That Heal (CTH) intervention as part of the HEALing
Communities Study (HCS). The HCS is a multi-site, parallel arm, cluster randomized, wait-list controlled trial
evaluating the impacts of the CTH intervention, compared with usual care in wait-list communities, on overdose
deaths. The overall goal of the HCS is to reduce opioid overdose deaths by 40% in 67 HCS communities
across four states. Communities form coalitions to make shared decisions about what overdose prevention
strategies to implement and how best to implement them, particularly strategies that promote Overdose
Prevention Education and Naloxone Distribution (OEND) and Medications for Opioid Use Disorder (MOUD).
Even though minoritized communities (whether due to race, ethnicity, gender, or LGBTQIA+ status) have less
and poorer access to treatment for Opioid Use Disorder (OUD) and associated disparities in outcomes at its
outset, HCS did not explicitly aim to reduce disparities or measure the effect of centering equity on overdose
prevention. This approach changed in 2020 with an acute awareness of the racial and ethnic disparities within
the COVID epidemic and the racial awakening in response to the George Floyd killing. This supplement will
leverage its parent study existing staff and infrastructure and study staff to analyze surveys and other
qualitative data already collected. The primary data sources will include surveys of coalition members,
completed at four-time points during the study period; the Opioid-Overdose Reduction Continuum of Care
Approach Tracker (ORCCAT), completed monthly by study staff, that includes overdose prevention information
by strategy, sector, venue, population served, coalition approval date, implementation plan developed, date
started, number of partners/practices associated with strategy, and mode of delivery; and REACH data,
completed by study staff monthly once each strategy is implemented that includes information on number of
persons reached and demographics of those reached (e.g., race, ethnicity, sex, age). Data analysis will consist
of qualitative analysis looking at associations between survey answers regarding health equity topics and
incorporation of equity into strategies, and qualitative analysis examining how coalitions discussed and
prioritized equity topics. The parent study’s PRISM/RE-AIM(S) conceptual framework will guide this study
with a novel health equity lens to examine how diversifying coalitions and infusing opioid overdose prevention
strategies with health equity principles may help reach minoritized communities and how these contextual
factors and processes may interact to promote or impede health equity. Results from this study may be used to
inform policies, strategies, and practices for incorporating health equity principles when implementing overdose
prevention strategies.
项目总结/文摘
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Economic Evaluation in Opioid Modeling: Systematic Review.
阿片类药物建模中的经济评估:系统评价。
- DOI:10.1016/j.jval.2020.07.013
- 发表时间:2021-03
- 期刊:
- 影响因子:0
- 作者:Beaulieu E;DiGennaro C;Stringfellow E;Connolly A;Hamilton A;Hyder A;Cerdá M;Keyes KM;Jalali MS
- 通讯作者:Jalali MS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nabila El-Bassel其他文献
Nabila El-Bassel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nabila El-Bassel', 18)}}的其他基金
Peer-based HIV Self-testing among High Risk Women Who Inject or Use Drugs in Kazakhstan, Central Asia
哈萨克斯坦、中亚地区注射或吸毒高危女性中基于同伴的艾滋病毒自我检测
- 批准号:
10458069 - 财政年份:2020
- 资助金额:
$ 83.3万 - 项目类别:
Peer-based HIV Self-testing among High Risk Women Who Inject or Use Drugs in Kazakhstan, Central Asia
哈萨克斯坦、中亚地区注射或吸毒高危女性中基于同伴的艾滋病毒自我检测
- 批准号:
10241546 - 财政年份:2020
- 资助金额:
$ 83.3万 - 项目类别:
Peer-based HIV Self-testing among High Risk Women Who Inject or Use Drugs in Kazakhstan, Central Asia
哈萨克斯坦、中亚地区注射或吸毒高危女性中基于同伴的艾滋病毒自我检测
- 批准号:
10082944 - 财政年份:2020
- 资助金额:
$ 83.3万 - 项目类别:
CHASE: An Innovative County-Level Public Health Response to the Opioid Epidemic in New York State
CHASE:针对纽约州阿片类药物流行病的创新县级公共卫生应对措施
- 批准号:
10391484 - 财政年份:2019
- 资助金额:
$ 83.3万 - 项目类别:
CHASE: An Innovative County-Level Public Health Response to the Opioid Epidemic in New York State
CHASE:针对纽约州阿片类药物流行病的创新县级公共卫生应对措施
- 批准号:
9917750 - 财政年份:2019
- 资助金额:
$ 83.3万 - 项目类别:
Improving HIV Service Delivery for People who Inject Drugs in Kazakhstan
改善哈萨克斯坦注射吸毒者的艾滋病毒服务
- 批准号:
9321424 - 财政年份:2015
- 资助金额:
$ 83.3万 - 项目类别:
Improving HIV Service Delivery for People who Inject Drugs in Kazakhstan
改善哈萨克斯坦注射吸毒者的艾滋病毒服务
- 批准号:
9054333 - 财政年份:2015
- 资助金额:
$ 83.3万 - 项目类别:
Improving HIV Service Delivery for People who Inject Drugs in Kazakhstan
改善哈萨克斯坦注射吸毒者的艾滋病毒服务
- 批准号:
9145168 - 财政年份:2015
- 资助金额:
$ 83.3万 - 项目类别:
Improving HIV Service Delivery for People who Inject Drugs in Kazakhstan
改善哈萨克斯坦注射吸毒者的艾滋病毒服务
- 批准号:
9517840 - 财政年份:2015
- 资助金额:
$ 83.3万 - 项目类别:
Training Program on HIV and Substance Use in the Criminal Justice System
刑事司法系统中的艾滋病毒和药物使用培训计划
- 批准号:
10396048 - 财政年份:2014
- 资助金额:
$ 83.3万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 83.3万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 83.3万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 83.3万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 83.3万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 83.3万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 83.3万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 83.3万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 83.3万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 83.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 83.3万 - 项目类别:
Standard Grant